Concepedia
Publication | Open Access
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: a phase I/II trial
47
Citations
28
References
2022
Year
ChiCTR1800015030.
Page 1